Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

19th Feb 2018 18:12

RNS Number : 3232F
GlaxoSmithKline PLC
19 February 2018
 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr N Hirons

b)

Position/status

SVP, Global Ethics & Compliance

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

GlaxoSmithKline plc American Depositary Shares ('ADSs')

ISIN: US37733W1053

 

b)

Nature of the transaction

The lapse of options over 4,600 ADSs, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan, at an option price of $44.75.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

2,366 (Incentive Stock Option)

n/a

2,234 (Non-Qualified Stock Option)

 

d)

Aggregated information 

Aggregated volume Price

4,600n/a

e)

Date of the transaction

2018-02-19

f)

Place of the transaction

 

n/a

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHVKLFFVLFFBBB

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77